Cargando…
Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cassette (ABC) family which are capable of conferring resistance to a variety of anticancer drugs, including taxanes and nucleoside analogs, in vivo. MRP7 is highly expressed in non-small cell lung cance...
Autores principales: | Sun, Yue-Li, Chen, Jun-Jiang, Kumar, Priyank, Chen, Kang, Sodani, Kamlesh, Patel, Atish, Chen, Yang-Lu, Chen, Si-Dong, Jiang, Wen-Qi, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564796/ https://www.ncbi.nlm.nih.gov/pubmed/23393594 http://dx.doi.org/10.1371/journal.pone.0055576 |
Ejemplares similares
-
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
por: Anreddy, Nagaraju, et al.
Publicado: (2014) -
BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10)
por: Chen, Jun-Jiang, et al.
Publicado: (2013) -
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
por: SUN, YUE-LI, et al.
Publicado: (2014) -
Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
por: Shen, Tong, et al.
Publicado: (2009) -
Correction: Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
por: Shen, Tong, et al.
Publicado: (2009)